{"disease":{"id":"tachycardia-paroxysmal-supraventricular","name":"tachycardia paroxysmal supraventricular"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05410860","title":"Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Corxel Pharmaceuticals","has_results":false},{"nct_id":"NCT04078685","title":"Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias","phase":"NA","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"Erasmus Medical Center","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}